FIBA 2010 FIBA vs Vernard Hollins

The International Basketball Federation (FIBA) has reported an anti-doping rule violation against the Player after his sample tested positive for the prohibited substance hydromorphone.
After notification the Player filed a statement and evidence in his defence and was heard for the FIBA Disciplinary Panel.
The Player stated he suffers from RTC syndrome in both his shoulders since the summer of 2009 which occasionally causes him sharp pain. Therefore his family doctor prescribed him the medication Acetimophen with Hydrocodone (hydromorphone) for the pain. His doctor confirmed having prescribed the medication to the Player.
The Player argued he used the medication shortly before the game and stated that the Acetimophen with Hydrocodone must have been the source of the prohibited substance.
The Panel accepts Player’s statement and finds Player’s negligence truly insignificant. Therefore the FIBA Disciplinary Panel decides a 1 month period of ineligibility.

Original document

Parameters

Legal Source
Decisions International Federations
Date
20 September 2010
Arbitrator
Günter, Heinz
Mizzi, Antonio
Original Source
International Basketball Federation (FIBA)
Country
United States of America
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
No Significant Fault or Negligence
Period of ineligibility
Sport/IFs
Basketball (FIBA) - International Basketball Federation
Laboratories
Lausanne, Switzerland: Laboratoire Suisse d’Analyse du Dopage
Doping classes
S7. Narcotics
Substances
Hydromorphone
Medical terms
Legitimate Medical Treatment
Document type
Pdf file
Date generated
11 September 2013
Date of last modification
27 February 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin